A most recent study suggested that NCCRP1 was highly expressed in triple-negative breast cancers (TNBCs) and its overexpression could markedly enhance cell proliferation (Zhou et al., 2022). This evidence concerns the gene NCCRP1 and triple-negative breast carcinoma.